April 24 - HCA Healthcare reported first-quarter adjusted profit that modestly exceeded Wall Street forecasts, citing ongoing demand for medical services as a supporting factor. The hospital operator said revenue per equivalent admission at same facilities - a combined metric for inpatient and outpatient activity - rose 3.1% in the quarter.
The company recorded adjusted earnings of $7.15 per share, compared with analysts' estimates of $7.14 per share according to data compiled by LSEG. Management highlighted elevated demand for non-urgent procedures, particularly among older Americans, a trend the company and other hospital operators have been seeing since the second half of 2023.
At the same time, HCA noted it did not experience the usual volume increase associated with the flu season. The company reported that respiratory-related admissions were down 42% year-over-year, and respiratory-related emergency room visits were down 32% year-over-year.
Investors reacted to the earnings release with a drop in the stock price, as shares of HCA fell 7.6% in premarket trading.
Context and operational indicators
The reported rise in revenue per equivalent admission offers a view into the mix and pricing dynamics across both inpatient and outpatient settings, while the year-over-year declines in respiratory-related admissions and emergency room visits point to weaker seasonal respiratory activity than might typically be expected. The company attributed its overall performance in part to sustained demand for elective, non-urgent procedures.
Investment tool mention
The company was also referenced in promotional material that asks whether an investor should place $2,000 into HCA right now. That material notes ProPicks AI evaluates HCA alongside thousands of other companies each month using more than 100 financial metrics. It states that the AI uses powerful algorithms to generate stock ideas, assessing fundamentals, momentum, and valuation without bias, and highlights past winners including Super Micro Computer with a gain of 185% and AppLovin with a gain of 157%. The material invites readers to see whether HCA is featured in any ProPicks AI strategies or whether there are other opportunities in the same sector.
Bottom line
HCA achieved adjusted earnings per share slightly above consensus and posted a modest increase in revenue per equivalent admission, driven by continuing demand for non-urgent care. At the same time, the expected seasonal pickup in respiratory cases did not materialize, with notable declines in respiratory admissions and emergency room visits compared with the prior year. The stock market reacted negatively in premarket trading.